Citations

Mayo Clinic

Clear

2435 citation(s) found for "Ou, Amy".

TADALAFIL IN THE TREATMENT OF ERECTILE DYSFUNCTION FOLLOWING BILATERAL NERVE SPARING RADICAL RETROPUBIC PROSTATECTOMY: A RANDOMIZED, DOUBLE-BLIND, PLACEBO CONTROLLED TRIAL
Montorsi, Francesco , Nathan, Harin Padma, McCullough, Andrew, Brock, Gerald, Broderick, Gregory A. , Ahuja, Sanjeev , Whitaker, Steve, Hoover, Amy M., NOVACK, DONNA, Varanese, Lucio, Murphy, Aileen

Journal of Urology | August 12, 2004 | Volume: 172 | Issue: 3 | Pages: 1036-1041

10.1097/01.ju.0000136448.71773.2b | PMID 15311032 Get It

MULTIPLE CALCIUM PHOSPHATE STONES OCCUPYING A CALICEAL DIVERTICULUM
Krambeck, Amy E. , LeRoy, Andrew J., Fisher, Dirk T., Segura, Joseph W.

Journal of Urology | June 2, 2004 | Volume: 172 | Issue: 1 | Pages: 164-165

10.1097/01.ju.0000129003.74499.2c | PMID 15201762 Get It

Prophylactic Mastectomy for BRCA1/2 Carriers: Progress and More Questions
Hartmann, Lynn C. , Schaid, Daniel J. , Degnim, Amy C.

Journal of Clinical Oncology | February 24, 2004 | Volume: 22 | Issue: 6 | Pages: 981-983

10.1200/jco.2004.01.925 | PMID 14981099 Get It

Unusual Lymphoma Manifestations
Harker-Murray, Amy, Locketz, Adam J., Thompson, Michael A. , Chareonthaitawee, Panithaya

Journal of Clinical Oncology | January 30, 2004 | Volume: 22 | Issue: 3 | Pages: 558-560

10.1200/jco.2004.12.100 | PMID 14752079 Get It

Compartment Syndrome in Surgical Patients
Warner, Mary E. , LaMaster, Lisa M., Thoeming, Amy K., Marienau, Mary E. Shirk, Warner, Mark A.

Anesthesiology | November 10, 2003 | Volume: 94 | Issue: 4 | Pages: 705-708

10.1097/00000542-200104000-00026 | PMID 11379693 Get It

Effect of Heparin II Domain of Fibronectin on Aqueous Outflow in Cultured Anterior Segments of Human Eyes
Santas, Amy J. , Bahler, Cindy K., Peterson, Jennifer A., Filla, Mark S. , Kaufman, Paul L., Tamm, Ernst R. , Peters, Donna M. , Johnson, Douglas H.

Investigative Opthalmology & Visual Science | October 24, 2003 | Volume: 44 | Issue: 11 | Pages: 4796

10.1167/iovs.02-1083 | PMID 14578401 Get It

The Caregivers’ Story: Home Caregiving for Persons with Dementia
Kelly, Ann W., Buckwalter, Kathleen C., Hall, Geri Richards, Weaver, Amy L. , Butcher, Howard K.

Home Health Care Management & Practice | April 28, 2003 | Volume: 14 | Issue: 2 | Pages: 99-109

10.1177/1084822302014002004 Get It

This study identified the salient issues of caregiving for family members of persons with dementia using computer-assisted content analysis followed by factor analysis. Differences in responses between caregivers in two treatment groups were also noted. Caregivers (N = 226) were interviewed on three occasions over 12 months. They consistently identified the following themes of caregiving in order of significance: (a) making meaning of the experience; (b) defining the caregiver role; (c) identifying specific caregiving strategies; (d) dealing with change, unpredictability, and vulnerability; (e) evaluating past and future decisions and quality of care; and (f) finding help and support. This representation of the caregiving experience is useful to home care nurses by providing a framework to address issues most important to caregivers and upon which therapeutic interventions can be developed.
Leukemia Inhibitory Factor is Augmented in the Heart in Experimental Heart Failure
Jougasaki, Michihisa , Leskinen, Hanna, Larsen, Amy, Cataliotti, Alessandro , Chen, Horng H. , Burnett, John C.

European Journal of Heart Failure | March 25, 2003 | Volume: 5 | Issue: 2 | Pages: 137-145

10.1016/s1388-9842(02)00236-2 | PMID 12644003 Get It

Abstract Leukemia inhibitory factor (LIF) is a pleiotropic cytokine that induces cardiac myocyte hypertrophy through the signal transducing molecule, glycoprotein 130. To date, localization of LIF in the heart and regulation of cardiac LIF expression in congestive heart failure (CHF) remain undefined. The present study investigates the potential activation of LIF expression in the failing canine heart that was produced by progressive rapid ventricular pacing. Immunohistochemistry for LIF revealed that LIF immunoreactivity was present in the atrial and ventricular myocytes of the normal heart and was markedly increased in the failing heart as compared to the normal heart. Northern blot analysis demonstrated that cardiac LIF mRNA was increased in both atrium and ventricle in CHF as compared to the normal heart (P<0.01). Linear regression analysis revealed a positive correlation between atrial LIF mRNA and atrial pressure (r=0.87, P<0.001 in right atrium and r=0.86, P<0.001 in left atrium). Positive correlations between left ventricular LIF mRNA and left ventricular dimensions (r=0.91, P<0.0001 in end-systolic diameter; r=0.86, P<0.001 in end-diastolic diameter), and an inverse correlation between left ventricular LIF mRNA and left ventricular ejection fraction (EF) were observed (r=−0.93, P<0.0001). There was a positive correlation between left ventricular LIF mRNA and left ventricular mass index (LVMI) (r=0.85, P<0.001). The present study demonstrates that cardiac LIF immunoreactivity and its gene expression are increased in a canine model of experimental CHF and suggests a potential role for LIF in the pathophysiology of CHF.
Ventilation Tube Removal: Does Treatment Affect Perforation Closure?
Schwartz, Kara M., Orvidas, Laura J. , Weaver, Amy L. , Thieling, Sarah

Otolaryngology–Head and Neck Surgery | February 4, 2003 | Volume: 126 | Issue: 6 | Pages: 663-668

10.1067/mhn.2002.125605 | PMID 12087335 Get It

OBJECTIVEThe study goal was to determine whether treatment of the tympanic membrane at the time of ventilation tube (VT) removal affects closure of the perforation.STUDY DESIGNWe conducted a retrospective chart review and telephone follow‐up of children who underwent VT removal from 1995 through 1998.RESULTSAmong 109 patients (162 ears; 58% male), the mean age at VT removal was 6.7 years. Most VTs (59%) were T‐tubes, and most (91%) were removed because of prolonged retention (mean 2.3 years). After VT removal, 111 ears (69%) received treatment, most commonly (44%) with 25% trichloroacetic acid (TCA). At the latest follow‐up, 151 of the ears (93%) had healed without additional treatment. Treatment failure occurred more frequently in ears not initially treated with TCA (TCA 3% failure, other treatment 13%, no treatment 8%) and in ears with VTs removed because of otorrhea.CONCLUSIONSMost perforations healed. TCA may promote closure, but a large randomized clinical trial is needed to eliminate physician bias.
Grading and Staging of Bladder Carcinoma in Transurethral Resection Specimens
Cheng, Liang , Neumann, Roxann M., Weaver, Amy L. , Cheville, John C. , Leibovich, Bradley C. , Ramnani, Dharamdas M., Scherer, Beth G., Nehra, Ajay, Zincke, Horst, Bostwick, David G., Cheng, Liang , Ramnani, Dharam M., Cheng, Liang

American Journal of Clinical Pathology | January 8, 2003 | Volume: 113 | Issue: 2 | Pages: 275-279

10.1309/94b6-8vfb-mn9j-1nf5 | PMID 10664630 Get It